Literature DB >> 11150167

Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.

A R Beauglehole1, S P Baker, P J Scammells.   

Abstract

FSCPX (1) has been reported to be a potent, selective, and irreversible antagonist for the A(1)-adenosine receptor (AR). To obtain an irreversible A(1)AR antagonist with potentially better stability and to further elucidate the effects of linker structure on the pharmacological characteristics, several new analogues were targeted in which the labile ester linkage of 1 was replaced by more stable functionalities. In particular, alkyl and amide linkers between the xanthine pharmacophore and the reactive 4-fluorosulfonylphenyl group were explored. The data showed that the chemical composition of the linker affects the affinity and apparent irreversible binding to the A(1)AR. Overall, compound 23b appeared to have the most advantageous characteristics as a potential irreversible ligand for the A(1)AR. These include relatively high affinity for the A(1)AR as compared to the A(2A)AR, concentration-dependent and selective apparent irreversible binding to the A(1)AR, and ease of removal of unbound ligand from biological membranes. These properties indicate that 23b has the potential to be a useful tool for further study of the structure and function of the A(1)AR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150167     DOI: 10.1021/jm000181f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Structure-based design and analysis of SuFEx chemical probes.

Authors:  Lyn H Jones; Jeffery W Kelly
Journal:  RSC Med Chem       Date:  2020-01-06

2.  Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive group.

Authors:  Bert L H Beerkens; Xuesong Wang; Maria Avgeropoulou; Lisa N Adistia; Jacobus P D van Veldhoven; Willem Jespers; Rongfang Liu; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  RSC Med Chem       Date:  2022-06-21

Review 3.  Molecular Simulations and Drug Discovery of Adenosine Receptors.

Authors:  Jinan Wang; Apurba Bhattarai; Hung N Do; Sana Akhter; Yinglong Miao
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

4.  Synthesis of Some Spiro Indeno[1,2-b]pyrido[2,3-d]Pyrimidine-5,3'-Indolines as New Urease Inhibitors.

Authors:  Ghodsi Mohammadi Ziarani; Shima Asadi; Alireza Badiei; Amirhossein Sharifi; Massoud Amanlou
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

Review 5.  Chemical Probes for the Adenosine Receptors.

Authors:  Stephanie Federico; Lucia Lassiani; Giampiero Spalluto
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-12

Review 6.  Molecular probes for the human adenosine receptors.

Authors:  Xue Yang; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  Purinergic Signal       Date:  2020-12-12       Impact factor: 3.765

Review 7.  International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.

Authors:  Adriaan P IJzerman; Kenneth A Jacobson; Christa E Müller; Bruce N Cronstein; Rodrigo A Cunha
Journal:  Pharmacol Rev       Date:  2022-04       Impact factor: 25.468

8.  Facile one-pot synthesis of sulfonyl fluorides from sulfonates or sulfonic acids.

Authors:  Ying Jiang; Njud S Alharbi; Bing Sun; Hua-Li Qin
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.